{"id":"amoxil-capsule","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Diarrhea"},{"rate":"3-5","effect":"Nausea"},{"rate":"1-3","effect":"Rash"},{"rate":"0.1-1","effect":"Allergic reaction / anaphylaxis"},{"rate":"2-5","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL206253","moleculeType":"Small molecule","molecularWeight":"578.60"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Amoxicillin works by disrupting the cross-linking of peptidoglycan in bacterial cell walls, leading to cell wall instability and bacterial lysis. It is bactericidal and effective against a broad spectrum of gram-positive and some gram-negative bacteria. The drug is commonly used to treat infections caused by susceptible organisms.","oneSentence":"Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:42:21.885Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections including otitis media, sinusitis, and respiratory tract infections"},{"name":"Urinary tract infections"},{"name":"Skin and soft tissue infections"},{"name":"Streptococcal pharyngitis"}]},"trialDetails":[{"nctId":"NCT06977841","phase":"NA","title":"Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Zhongshan Hospital (Xiamen), Fudan University","startDate":"2025-06-10","conditions":"Helicobacter Pylori Eradication, Adverse Reaction","enrollment":640},{"nctId":"NCT05834036","phase":"PHASE4","title":"Effect of Antibiotics on Enteric Neurons and Glia","status":"COMPLETED","sponsor":"Rockefeller University","startDate":"2023-06-23","conditions":"Antibiotic Enterocolitis","enrollment":10},{"nctId":"NCT05398679","phase":"PHASE4","title":"Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis","status":"RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2022-08-17","conditions":"Endocarditis Infective","enrollment":360},{"nctId":"NCT06340724","phase":"PHASE3","title":"Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-02-15","conditions":"Helicobacter Pylori Infection","enrollment":104},{"nctId":"NCT07224035","phase":"PHASE4","title":"Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2022-10-15","conditions":"H Pylori Infection, H Pylori Gastritis, Gastric Cancer","enrollment":500},{"nctId":"NCT07382661","phase":"PHASE1","title":"Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin","status":"NOT_YET_RECRUITING","sponsor":"Daewon Pharmaceutical Co., Ltd.","startDate":"2026-02","conditions":"Healthy Adult Volunteers","enrollment":36},{"nctId":"NCT06229288","phase":"PHASE3","title":"Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2024-04-25","conditions":"Community-acquired Pneumonia","enrollment":326},{"nctId":"NCT06681246","phase":"NA","title":"The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment","status":"RECRUITING","sponsor":"Weizmann Institute of Science","startDate":"2024-12-11","conditions":"Obesity, Weight Loss","enrollment":200},{"nctId":"NCT05647278","phase":"PHASE4","title":"Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)","status":"COMPLETED","sponsor":"Zhang Xiaofeng,MD","startDate":"2023-11-01","conditions":"Helicobacter Pylori Infection","enrollment":370},{"nctId":"NCT07294846","phase":"PHASE1","title":"Drug Interaction Study on Linaprazan Glurate Capsules","status":"COMPLETED","sponsor":"Jiangsu Sinorda Biomedicine Co., Ltd","startDate":"2025-09-08","conditions":"Healthy Volunteers, Patients","enrollment":56},{"nctId":"NCT07296302","phase":"NA","title":"Antibiotic Prophylaxis Versus Placebo in Alveolar Bone Grafting: A Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Agnaldo Rocha de Souza Junior","startDate":"2026-02","conditions":"Alveolar Ridge Augmentation, Bone Grafting, Antibiotic Prophylaxis","enrollment":150},{"nctId":"NCT07304882","phase":"PHASE3","title":"A Comparison of Recovery After Impacted Wisdom Tooth Removal","status":"COMPLETED","sponsor":"University of Science and Technology, Yemen","startDate":"2023-11-30","conditions":"Impacted Mandibular Third Molar Extraction, Post Operative Complications","enrollment":24},{"nctId":"NCT06751121","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2024-02-06","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients, Helicobacter Pylori Infected Subjects","enrollment":461},{"nctId":"NCT06126731","phase":"PHASE1, PHASE2","title":"Combination Study of Antibiotics With Enzalutamide (PROMIZE)","status":"RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2023-11-02","conditions":"Metastatic Castration-Resistant Prostate Cancer (mCRPC)","enrollment":39},{"nctId":"NCT05846399","phase":"PHASE4","title":"CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)","status":"RECRUITING","sponsor":"University of Missouri-Columbia","startDate":"2023-09-07","conditions":"Cat Bite, Hand Injuries, Arm Injury","enrollment":72},{"nctId":"NCT06451913","phase":"PHASE4","title":"Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))","status":"RECRUITING","sponsor":"Biocodex","startDate":"2025-07-16","conditions":"Erythema Migrans of Lyme Disease","enrollment":120},{"nctId":"NCT05857163","phase":"PHASE3","title":"Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infection","status":"COMPLETED","sponsor":"TenNor Therapeutics (Suzhou) Limited","startDate":"2023-05-18","conditions":"H.Pylori Infection","enrollment":700},{"nctId":"NCT06131021","phase":"PHASE3","title":"Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2024-04-25","conditions":"Periodontitis, Periodontal Diseases, Periodontal Pocket","enrollment":150},{"nctId":"NCT06168084","phase":"PHASE4","title":"Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Yongquan Shi","startDate":"2023-06-06","conditions":"Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer","enrollment":688},{"nctId":"NCT05742568","phase":"PHASE4","title":"Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2022-12-01","conditions":"Gastritis, Dyspepsia, Helicobacter Pylori Infection","enrollment":124},{"nctId":"NCT05266040","phase":"PHASE2","title":"Valacyclovir in Pain Management of Acute Apical Abscesses","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-10-25","conditions":"Acute Apical Abscess, Pain, Acute","enrollment":60},{"nctId":"NCT06166667","phase":"NA","title":"Effect of Fecal Capsule on Chronic Kidney Disease (CKD)","status":"COMPLETED","sponsor":"Shanxi Provincial People's Hospital","startDate":"2023-03-01","conditions":"Renal Insufficiency, Chronic","enrollment":20},{"nctId":"NCT06292546","phase":"NA","title":"The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment","status":"COMPLETED","sponsor":"Zhongshan Hospital (Xiamen), Fudan University","startDate":"2024-01-31","conditions":"Gut Microbiota, Metabolic Disturbance, Helicobacter Pylori Eradication","enrollment":72},{"nctId":"NCT06197308","phase":"EARLY_PHASE1","title":"Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-03-01","conditions":"Primary Sclerosing Cholangitis","enrollment":28},{"nctId":"NCT06901375","phase":"EARLY_PHASE1","title":"Zuojin Wan Combined with Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-05","conditions":"Helicobacter Pylori Infection","enrollment":136},{"nctId":"NCT05934227","phase":"NA","title":"Amoxicillin Plus Metronidazole in Periodontal Maintenance","status":"COMPLETED","sponsor":"Federal University of Minas Gerais","startDate":"2023-07-01","conditions":"Periodontitis, Periodontal Pocket","enrollment":50},{"nctId":"NCT06851468","phase":"NA","title":"Keverprazan Combined with Amoxicillin for the Treatment of Helicobacter Pylori","status":"NOT_YET_RECRUITING","sponsor":"Key Laboratory for Gastrointestinal Diseases of Gansu Province","startDate":"2025-03-15","conditions":"Helicobacter Pylori","enrollment":264},{"nctId":"NCT06576882","phase":"PHASE3","title":"7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-06-30","conditions":"Helicobacter Pylori Infection, Gastritis, Vonoprazan","enrollment":326},{"nctId":"NCT05957432","phase":"PHASE2","title":"Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ain Shams University","startDate":"2023-08-15","conditions":"Helicobacter Pylori Infection","enrollment":90},{"nctId":"NCT06613776","phase":"PHASE4","title":"Evaluation of the Effect of Antibiotic Prophylaxis (2g Amoxicillin One Hour Before Surgery) on an Inflammatory Factor (PGE2) in Salivary Samples After Third Molars Surgery","status":"COMPLETED","sponsor":"Universidad Católica San Antonio de Murcia","startDate":"2023-10-05","conditions":"Healthy, Third Molar Extraction Surgery, Antibiotic Prophylaxis","enrollment":18},{"nctId":"NCT06162949","phase":"PHASE3","title":"Vonoprazan for Helicobacter Pylori Eradication in Adolescents","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-01-01","conditions":"Treatment Effectiveness","enrollment":242},{"nctId":"NCT05649709","phase":"PHASE4","title":"Helicobacter Pylori and Vonoprazan Dual Therapy","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Nanchang University","startDate":"2023-02-13","conditions":"Helicobacter Pylori","enrollment":504},{"nctId":"NCT00750750","phase":"PHASE2","title":"Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-01-01","conditions":"Acute Rhinosinusitis","enrollment":981},{"nctId":"NCT00751075","phase":"PHASE3","title":"Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-12-01","conditions":"Acute Rhinosinusitis","enrollment":981},{"nctId":"NCT05749081","phase":"PHASE4","title":"Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"The First Affiliated Hospital of Nanchang University","startDate":"2023-05-13","conditions":"Helicobacter Pylori Infection","enrollment":324},{"nctId":"NCT06277609","phase":"PHASE1","title":"A Trial Investigating Lu AF28996 in Healthy Adult Participants","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2024-02-27","conditions":"Healthy Participants","enrollment":22},{"nctId":"NCT06250634","phase":"NA","title":"Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2024-02-10","conditions":"Helicobacter Pylori Infection","enrollment":806},{"nctId":"NCT06250413","phase":"NA","title":"Autoflor -Lyophilized Capsulated Autological FMT to Restore Gut Microbiome After Treatment With Antibiotics","status":"NOT_YET_RECRUITING","sponsor":"Otto Helve","startDate":"2024-02","conditions":"Microbial Colonization, Antibiotic Side Effect","enrollment":40},{"nctId":"NCT06216639","phase":"","title":"Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection","status":"UNKNOWN","sponsor":"National Institute of Public Health, Slovenia","startDate":"2024-02-01","conditions":"Helicobacter Pylori Infection","enrollment":2000},{"nctId":"NCT05577468","phase":"PHASE3","title":"Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","startDate":"2022-10-30","conditions":"Helicobacter Pylori Infection","enrollment":561},{"nctId":"NCT06076694","phase":"PHASE2","title":"Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants","status":"COMPLETED","sponsor":"TenNor Therapeutics (Suzhou) Limited","startDate":"2022-06-26","conditions":"Helicobacter Pylori Infection","enrollment":80},{"nctId":"NCT06076681","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules","status":"COMPLETED","sponsor":"TenNor Therapeutics (Suzhou) Limited","startDate":"2021-09-27","conditions":"Helicobacter Pylori Infection","enrollment":40},{"nctId":"NCT06101420","phase":"PHASE3","title":"Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"Helicobacter Pylori Eradication","enrollment":232},{"nctId":"NCT04198363","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Takeda","startDate":"2020-04-30","conditions":"Helicobacter Pylori","enrollment":510},{"nctId":"NCT04753437","phase":"PHASE1","title":"A Study of Vonoprazan in Adults With Helicobacter Pylori","status":"COMPLETED","sponsor":"Takeda","startDate":"2021-04-06","conditions":"Helicobacter Pylori","enrollment":44},{"nctId":"NCT05915871","phase":"PHASE1","title":"Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin","status":"COMPLETED","sponsor":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","startDate":"2023-03-23","conditions":"Healthy","enrollment":22},{"nctId":"NCT05863858","phase":"PHASE3","title":"Eradication of H. Pylori Infection With Moxifloxacin","status":"COMPLETED","sponsor":"Iyad Naeem Muhammad, PhD","startDate":"2020-06-01","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to","enrollment":162},{"nctId":"NCT02332577","phase":"PHASE4","title":"Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia","status":"TERMINATED","sponsor":"Sanofi","startDate":"2015-04-30","conditions":"Pneumonia","enrollment":161},{"nctId":"NCT04408508","phase":"NA","title":"Safety and Efficacy of an Oral Penicillin Challenge in Low Risk Hospitalized Patients","status":"UNKNOWN","sponsor":"Saskatchewan Health Authority - Regina Area","startDate":"2023-12","conditions":"Penicillin Allergy","enrollment":50},{"nctId":"NCT04678492","phase":"PHASE4","title":"Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-12-20","conditions":"Gastritis, Dyspepsia, Helicobacter Pylori Infection","enrollment":658},{"nctId":"NCT04850209","phase":"NA","title":"The Impact of WeChat Group Patient Education on the Eradication Rate of Helicobacter Pylori","status":"COMPLETED","sponsor":"Shandong University","startDate":"2021-07-23","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori Eradication, Patient Education","enrollment":438},{"nctId":"NCT04697186","phase":"PHASE4","title":"Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2021-01-07","conditions":"Dyspepsia, Chronic Gastritis, Gastric Cancer","enrollment":524},{"nctId":"NCT05674864","phase":"NA","title":"Effect of Probiotics on Eradication of Persistent H.Pylori Infection","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2023-01-01","conditions":"Persistent Helicobacter Pylori Infection","enrollment":92},{"nctId":"NCT05410223","phase":"NA","title":"Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2021-04-06","conditions":"Helicobacter Pylori Infection","enrollment":100},{"nctId":"NCT05590286","phase":"PHASE4","title":"A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"First People's Hospital of Hangzhou","startDate":"2022-06-01","conditions":"Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor","enrollment":100},{"nctId":"NCT02185209","phase":"PHASE4","title":"Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics","status":"COMPLETED","sponsor":"Margareta Hultin","startDate":"2015-03","conditions":"Periodontal Diseases, Periimplantitis","enrollment":77},{"nctId":"NCT04167670","phase":"PHASE3","title":"Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Phathom Pharmaceuticals, Inc.","startDate":"2019-12-10","conditions":"Helicobacter Pylori Infection","enrollment":1046},{"nctId":"NCT03342456","phase":"PHASE4","title":"The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers","status":"COMPLETED","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2017-12-13","conditions":"Duodenal Ulcer Due to Helicobacter Pylori","enrollment":184},{"nctId":"NCT05237115","phase":"PHASE4","title":"Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-05-05","conditions":"Gastritis, Peptic Ulcer, Dyspepsia","enrollment":600},{"nctId":"NCT05194046","phase":"PHASE1","title":"Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers","status":"COMPLETED","sponsor":"Onconic Therapeutics Inc.","startDate":"2020-11-18","conditions":"Helicobacter Pylori Associated Gastrointestinal Disease","enrollment":29},{"nctId":"NCT04558502","phase":"PHASE4","title":"Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-01-05","conditions":"Helicobacter Pylori Eradication","enrollment":339},{"nctId":"NCT02323412","phase":"PHASE3","title":"Antibiotics In Modic Changes","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2015-06","conditions":"Low Back Pain, Modic Changes Type I or II Seen on MRI","enrollment":180},{"nctId":"NCT04901663","phase":"PHASE4","title":"Vonoprazan in Helicobacter Pylori Treatment an RCT","status":"COMPLETED","sponsor":"Dow University of Health Sciences","startDate":"2021-06-21","conditions":"Helicobacter Pylori Infection","enrollment":179},{"nctId":"NCT03050307","phase":"PHASE3","title":"Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Takeda","startDate":"2017-04-17","conditions":"Gastric Ulcer","enrollment":234},{"nctId":"NCT04209933","phase":"PHASE4","title":"Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-05-25","conditions":"Gastric Cancer, Helicobacter Pylori Infection, Bismuth","enrollment":240},{"nctId":"NCT03582605","phase":"EARLY_PHASE1","title":"Antibiotics Prior to Mini-screw Implant Insertion","status":"COMPLETED","sponsor":"St. Louis University","startDate":"2018-08-07","conditions":"Inflammation at Mini-screw Insertion Site, Mobility, Mini-screw","enrollment":31},{"nctId":"NCT04617613","phase":"PHASE4","title":"Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2016-09","conditions":"Helicobacter Pylori Infection","enrollment":603},{"nctId":"NCT03374176","phase":"PHASE3","title":"Efficacy of Amoxicillin-metronidazole Compared to Clindamycin in Patients With Periodontitis and Diabetes","status":"COMPLETED","sponsor":"Centro Universitario de Tonalá","startDate":"2014-03","conditions":"Periodontitis, Periodontal Pocket, Diabetes Mellitus","enrollment":42},{"nctId":"NCT02241421","phase":"NA","title":"The Importance of the Gut Microbiota in Body Weight Control and Insulin Sensitivity","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2012-04","conditions":"Obesity, Insulin Resistance","enrollment":57},{"nctId":"NCT03211156","phase":"PHASE2","title":"Treatment of Gardnerella Vaginalis Vaginal Colonization With Amoxicillin","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-09-11","conditions":"Vaginitis Gardnerella","enrollment":97},{"nctId":"NCT04444011","phase":"PHASE1","title":"Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth","status":"UNKNOWN","sponsor":"Sihuan Pharmaceutical Holdings Group Ltd.","startDate":"2020-07-01","conditions":"Healthy Male Volunteers","enrollment":32},{"nctId":"NCT03050359","phase":"PHASE3","title":"Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Takeda","startDate":"2017-04-05","conditions":"Duodenal Ulcer","enrollment":533},{"nctId":"NCT02490839","phase":"PHASE4","title":"Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2015-07","conditions":"Helicobacter Pylori Infection","enrollment":450},{"nctId":"NCT03198507","phase":"PHASE3","title":"ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2017-06-18","conditions":"Helicobacter Pylori Infection, Dyspepsia","enrollment":455},{"nctId":"NCT04209777","phase":"PHASE3","title":"Clinical Evaluation of Smoker Periodontal Subjects After Lactobacillus-reuteri Probiotics and Antibiotics Therapy","status":"COMPLETED","sponsor":"Dow University of Health Sciences","startDate":"2018-07-08","conditions":"Periodontal Diseases, Smoking","enrollment":66},{"nctId":"NCT01980095","phase":"PHASE3","title":"ERADICATE Hp - Treating Helicobacter Pylori With RHB-105","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2013-11","conditions":"Dyspepsia, Helicobacter Pylori Infection","enrollment":119},{"nctId":"NCT03609892","phase":"PHASE4","title":"Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2018-08-01","conditions":"Gastric Ulcer, Chronic Gastritis, Gastric Cancer","enrollment":658},{"nctId":"NCT02483715","phase":"PHASE4","title":"Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2015-07","conditions":"Helicobacter Pylori Infection","enrollment":589},{"nctId":"NCT03499184","phase":"NA","title":"Adjunctive Probiotics in Chronic Periodontitis","status":"COMPLETED","sponsor":"Ziauddin Hospital","startDate":"2017-11-01","conditions":"Chronic Periodontitis, Probiotics","enrollment":60},{"nctId":"NCT02605122","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia","status":"TERMINATED","sponsor":"Melinta Therapeutics, Inc.","startDate":"2016-04","conditions":"Community-acquired Bacterial Pneumonia","enrollment":97},{"nctId":"NCT02892409","phase":"PHASE1","title":"TAK-438 Bismuth Drug Interaction Study","status":"COMPLETED","sponsor":"Takeda","startDate":"2016-09-05","conditions":"Helicobacter Pylori","enrollment":30},{"nctId":"NCT03021590","phase":"PHASE4","title":"Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori","status":"WITHDRAWN","sponsor":"Damascus Hospital","startDate":"2017-06-01","conditions":"Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":""},{"nctId":"NCT03243032","phase":"EARLY_PHASE1","title":"Pre-Emptive Analgesia in Dental Implant Surgery","status":"WITHDRAWN","sponsor":"Satheesh Elangovan","startDate":"2017-10-06","conditions":"Pain, Postoperative","enrollment":""},{"nctId":"NCT03704506","phase":"PHASE4","title":"Registration of the Study of Reyanning Mixture","status":"UNKNOWN","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2018-10-22","conditions":"Acute Tonsillitis","enrollment":144},{"nctId":"NCT03588273","phase":"NA","title":"Effect of Stomach Reduction Surgery on the Parameters of Amoxicillin","status":"COMPLETED","sponsor":"Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara","startDate":"2016-06-24","conditions":"Bariatric Surgery Candidate","enrollment":8},{"nctId":"NCT03208426","phase":"PHASE4","title":"Sequential Versus Quadruple Therapy in the Second-line Treatment","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2017-10-01","conditions":"Helicobacter Pylori Infection","enrollment":240},{"nctId":"NCT03428568","phase":"PHASE2","title":"Safety Trial of Herbal Melanin in Gastritis Patients","status":"UNKNOWN","sponsor":"King Abdullah International Medical Research Center","startDate":"2018-03","conditions":"Acid Dyspepsia, Gastritis","enrollment":132},{"nctId":"NCT03165253","phase":"NA","title":"The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children","status":"COMPLETED","sponsor":"Bulent Ecevit University","startDate":"2011-06","conditions":"Helicobacter Pylori Infection","enrollment":69},{"nctId":"NCT02693574","phase":"PHASE4","title":"Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori","status":"UNKNOWN","sponsor":"Damascus Hospital","startDate":"2015-12-01","conditions":"Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":74},{"nctId":"NCT00669955","phase":"PHASE3","title":"Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2008-06","conditions":"Helicobacter Infections","enrollment":440},{"nctId":"NCT02633930","phase":"PHASE4","title":"Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2015-12","conditions":"Gastritis, Peptic Ulcer, Dyspepsia","enrollment":566},{"nctId":"NCT02131818","phase":"PHASE4","title":"Necessity of Antibiotics for Prevention of Delivery-associated Infections After Spontaneous Vaginal Delivery at Term","status":"TERMINATED","sponsor":"Mahidol University","startDate":"2014-05","conditions":"Perineal Wound Infection","enrollment":5},{"nctId":"NCT02401477","phase":"PHASE4","title":"Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2014-12","conditions":"Helicobacter Infections","enrollment":90},{"nctId":"NCT02296021","phase":"PHASE4","title":"Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2014-11","conditions":"Gastritis, Peptic Ulcer, Dyspepsia","enrollment":612},{"nctId":"NCT02352701","phase":"","title":"Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori","status":"COMPLETED","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2012-12","conditions":"Helicobacter Infections","enrollment":320},{"nctId":"NCT00272467","phase":"PHASE4","title":"Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy","status":"COMPLETED","sponsor":"Korea Otsuka International Asia Arab","startDate":"2005-07","conditions":"Stomach Ulcer","enrollment":132},{"nctId":"NCT00887276","phase":"PHASE4","title":"Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia","status":"TERMINATED","sponsor":"University of Ulm","startDate":"2008-11","conditions":"Community Acquired Pneumonia","enrollment":290},{"nctId":"NCT01941160","phase":"PHASE1, PHASE2","title":"Effect of a Lacidofil® STRONG in Healthy Adults Taking Antibiotic Treatment","status":"COMPLETED","sponsor":"KGK Science Inc.","startDate":"2013-08","conditions":"Antibiotic Associated Diarrhea","enrollment":160},{"nctId":"NCT01505127","phase":"PHASE3","title":"Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori","status":"COMPLETED","sponsor":"Takeda","startDate":"2012-01","conditions":"H. Pylori Infection","enrollment":650},{"nctId":"NCT01566266","phase":"NA","title":"Gut Flora and Lipid Metabolism","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2012-03","conditions":"Hypercholesterolemia","enrollment":77}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":162,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["amoxicillin"],"phase":"marketed","status":"active","brandName":"amoxil capsule","genericName":"amoxil capsule","companyName":"China Academy of Chinese Medical Sciences","companyId":"china-academy-of-chinese-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Used for Bacterial infections including otitis media, sinusitis, and respiratory tract infections, Urinary tract infections, Skin and soft tissue infections.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}